JP2008500009A5 - - Google Patents

Download PDF

Info

Publication number
JP2008500009A5
JP2008500009A5 JP2006532309A JP2006532309A JP2008500009A5 JP 2008500009 A5 JP2008500009 A5 JP 2008500009A5 JP 2006532309 A JP2006532309 A JP 2006532309A JP 2006532309 A JP2006532309 A JP 2006532309A JP 2008500009 A5 JP2008500009 A5 JP 2008500009A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2006532309A
Other languages
Japanese (ja)
Other versions
JP2008500009A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2004/006460 external-priority patent/WO2005051988A2/en
Publication of JP2008500009A publication Critical patent/JP2008500009A/ja
Publication of JP2008500009A5 publication Critical patent/JP2008500009A5/ja
Pending legal-status Critical Current

Links

JP2006532309A 2003-03-03 2004-03-02 全身性エリテマトーデスの治療のための組成物と方法 Pending JP2008500009A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US45188403P 2003-03-03 2003-03-03
PCT/US2004/006460 WO2005051988A2 (en) 2003-03-03 2004-03-02 Compositions and methods for the treatment of systemic lupus erythematosis

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2010089887A Division JP2010207229A (ja) 2003-03-03 2010-04-08 全身性エリテマトーデスの治療のための組成物と方法

Publications (2)

Publication Number Publication Date
JP2008500009A JP2008500009A (ja) 2008-01-10
JP2008500009A5 true JP2008500009A5 (https=) 2009-05-14

Family

ID=34632721

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2006532309A Pending JP2008500009A (ja) 2003-03-03 2004-03-02 全身性エリテマトーデスの治療のための組成物と方法
JP2010089887A Pending JP2010207229A (ja) 2003-03-03 2010-04-08 全身性エリテマトーデスの治療のための組成物と方法
JP2013121971A Pending JP2013240329A (ja) 2003-03-03 2013-06-10 全身性エリテマトーデスの治療のための組成物と方法

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2010089887A Pending JP2010207229A (ja) 2003-03-03 2010-04-08 全身性エリテマトーデスの治療のための組成物と方法
JP2013121971A Pending JP2013240329A (ja) 2003-03-03 2013-06-10 全身性エリテマトーデスの治療のための組成物と方法

Country Status (6)

Country Link
US (2) US7749695B2 (https=)
EP (1) EP1599498A2 (https=)
JP (3) JP2008500009A (https=)
AU (2) AU2004293369A1 (https=)
CA (1) CA2518101A1 (https=)
WO (1) WO2005051988A2 (https=)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7790861B2 (en) * 1999-09-24 2010-09-07 Philadelphia Health And Education Corporation Prostate cancer-related compositions, methods, and kits based on DNA macroarray proteomics platforms
US20020042062A1 (en) * 1999-09-24 2002-04-11 Mark Stearns Prostate cancer-related compositions, methods, and kits based on DNA macroarray proteomics platforms
US7754435B2 (en) * 2000-09-21 2010-07-13 Philadelphia Health And Education Corporation Prostate cancer-related compositions, methods, and kits based on DNA macroarray proteomics platforms
WO2007043103A1 (ja) * 2005-09-30 2007-04-19 Kansai Technology Licensing Organization Co., Ltd. シェーグレン症候群診断法及び診断キット
WO2007127756A2 (en) 2006-04-24 2007-11-08 Genentech, Inc. Methods and compositions for detecting autoimmune disorders
CA2653071A1 (en) * 2006-05-25 2007-12-06 Sophie Brouard Methods for diagnosing and treating graft rejection and inflammatory conditions
EP1905841A1 (en) * 2006-09-25 2008-04-02 Max Delbrück Centrum für Molekulare Medizin (MDC) Berlin-Buch; Trex1 as a marker for lupus erythematosus
WO2010011965A2 (en) * 2008-07-24 2010-01-28 The Regents Of The University Of California Identifying high risk clinically isolated syndrome patients
US20120251546A1 (en) * 2009-09-03 2012-10-04 Medimmune Llc Type 1 inteferon diagnostic
WO2012042480A1 (en) 2010-09-28 2012-04-05 Kahr Medical Ltd. Compositions and methods for treatment of hematological malignancies
EP2831109B1 (en) 2012-03-28 2017-12-06 Gadeta B.V. Combinatorial gamma 9 delta 2 t cell receptor chain exchange
JP2019525898A (ja) 2016-06-10 2019-09-12 ガデタ・ベー・フェー ヒト白血球抗原拘束ガンマデルタt細胞受容体及びその使用方法
JP2019535834A (ja) * 2016-11-18 2019-12-12 ユニベルシタ デ バルセロナ 感染症及び関連炎症プロセスの処置のためのcd6及びイミペネムの併用療法
CN110506057B (zh) 2017-02-17 2023-09-29 百时美施贵宝公司 Alpha突触核蛋白抗体及其应用
US20230210942A1 (en) * 2018-01-09 2023-07-06 Imagine Pharma Llc Methods and compositions for modulating endothelial cell dysfunction
GB202012804D0 (en) * 2020-08-17 2020-09-30 Univ London Queen Mary Agrin polypeptide and uses thereof

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1666192A (en) * 1991-03-22 1992-10-21 Sloan-Kettering Institute For Cancer Research Methods for detection and treatment of cancer
CA2343006A1 (en) * 1998-09-17 2000-03-23 Genentech, Inc. Compositions and methods for the treatment of immune related diseases
CA2362427A1 (en) * 1999-03-08 2000-09-14 Genentech, Inc. Compositions and methods for the treatment of immune related diseases
JP2002543764A (ja) * 1999-03-19 2002-12-24 ヒューマン ジノーム サイエンシーズ, インコーポレイテッド 46個のヒト分泌タンパク質
JP4211966B2 (ja) * 1999-11-30 2009-01-21 ジェネンテック・インコーポレーテッド 免疫関連疾患を治療するための組成物及び方法
ES2379101T3 (es) * 1999-12-23 2012-04-20 Genentech, Inc. Polipéptidos homólogos IL-17 y usos terapéuticos de los mismos
CA2399776A1 (en) * 2000-02-03 2001-08-09 Hyseq, Inc. Novel nucleic acids and polypeptides
US6436703B1 (en) 2000-03-31 2002-08-20 Hyseq, Inc. Nucleic acids and polypeptides
WO2001075166A2 (en) 2000-03-31 2001-10-11 Genentech, Inc. Compositions and methods for detecting and quantifying gene expression
AU2001274888A1 (en) * 2000-05-19 2001-12-03 Human Genome Sciences, Inc. Nucleic acids, proteins, and antibodies
JP2004528810A (ja) * 2000-10-02 2004-09-24 バイエル コーポレーション 癌組織でディファレンシャルに発現される核酸配列
US20020137081A1 (en) * 2001-01-08 2002-09-26 Olga Bandman Genes differentially expressed in vascular tissue activation
WO2002057454A2 (en) 2001-01-19 2002-07-25 Incyte Genomics, Inc. Receptors and membrane-associated proteins
WO2003010327A2 (en) * 2001-02-21 2003-02-06 Curagen Corporation Novel proteins and nucleic acids encoding same
WO2003016475A2 (en) * 2001-08-14 2003-02-27 The General Hospital Corporation Nucleic acid and amino acid sequences involved in pain
US6489153B1 (en) * 2001-10-31 2002-12-03 Pe Corporation (Ny) Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
EP2388265A1 (en) * 2002-02-22 2011-11-23 Genentech, Inc. Compositions and methods for the treatment of immune related diseases
JP2004121218A (ja) * 2002-08-06 2004-04-22 Jenokkusu Soyaku Kenkyusho:Kk 気管支喘息または慢性閉塞性肺疾患の検査方法
US7118865B2 (en) * 2002-08-16 2006-10-10 Regents Of The University Of Minnesota Methods for diagnosing severe systemic lupus erythematosus
EP2116551A1 (en) * 2002-09-11 2009-11-11 Genentech, Inc. Compositions and methods for the treatment of immune related diseases
AU2003279084A1 (en) * 2002-09-25 2004-04-19 Genentech, Inc. Novel compositions and methods for the treatment of psoriasis
US20070224201A1 (en) * 2002-10-02 2007-09-27 Genentech, Inc. Compositions and methods for the diagnosis and treatment of tumor
WO2004043397A2 (en) * 2002-11-12 2004-05-27 Genentech, Inc. Compositions and methods for the treatment of rheumatoid arthritis
EP1572116A4 (en) * 2002-11-26 2007-12-12 Genentech Inc COMPOSITIONS AND METHODS FOR THE TREATMENT OF IMMUNE DISEASES
US20040191818A1 (en) * 2003-02-26 2004-09-30 O'toole Margot Mary Compositions and methods for diagnosing and treating autoimmune diseases

Similar Documents

Publication Publication Date Title
BE2024C508I2 (https=)
BE2023C542I2 (https=)
BE2022C549I2 (https=)
BE2021C001I2 (https=)
BE2020C513I2 (https=)
BE2020C517I2 (https=)
BE2019C540I2 (https=)
BE2019C523I2 (https=)
BE2019C548I2 (https=)
BE2019C506I2 (https=)
BE2020C525I2 (https=)
BE2018C045I2 (https=)
BE2017C063I2 (https=)
BE2017C027I2 (https=)
BE2017C023I2 (https=)
BE2017C002I2 (https=)
BE2016C067I2 (https=)
BE2016C014I2 (https=)
BE2015C041I2 (https=)
BE2015C038I2 (https=)
BE2014C010I2 (https=)
BE2015C066I2 (https=)
JP2005046158A5 (https=)
JP2005084049A5 (https=)
BE2015C033I2 (https=)